Company: LPSN
Filing Date: 2025-09-17
Form Type: DEF 14A
Source: 0001102993-25-000159
Chunk: 38

Company: LIVEPERSON INC
Filing Date: 2025-09-17
Form: DEF 14A
Chunk 38
---
 Authorized Common Stock Increase Proposal and the Reverse Stock Split Proposal are both approved, any other Reverse Stock Split ratio within the Ratio Range would result in a number of authorized shares of common stock between 15,000,000 and 60,000,000. If the Reverse Stock Split Proposal, but not the Authorized Common Stock Proposal, is approved, any other Reverse Stock Split Ratio within the Ratio Range would result in a number of authorized shares of common stock between 10,000,000 and 40,000,000.

The description of the Authorized Common Stock Increase Proposal is qualified in its entirety by and should be read in conjunction with the full text of the Authorized Common Stock Increase Certificate of Amendment, which is attached hereto as Appendix B .

#### 27 Proxy Statement
Proposal No. 2: Authorized Common Stock Increase Proposal

Effects of Approving the Authorized Common Stock Increase Proposal

If the Authorized Common Stock Increase Proposal is approved, the 26,551 outstanding shares of Series B Preferred Stock will convert into 23,217,594 shares of common stock (subject to the Beneficial Ownership Limitation and subject to proportional adjustment for any Reverse Stock Split or any other splits, combination, or similar adjustments) within one business day following the filing and acceptance of the Authorized Common Stock Increase Certificate of Amendment with the Secretary of State of the State of Delaware. Accordingly, if the Authorized Common Stock Increase Proposal is approved, the issuance of the Conversion Shares will significantly dilute, and thereby reduce, each existing stockholder’s proportionate ownership in our common stock. Such issuances will also significantly dilute the voting power of a person seeking control of the Company, thereby deterring, or rendering more difficult, a merger, tender offer, proxy contest or an extraordinary corporate transaction opposed by the Company. Stockholders do not have preemptive rights to subscribe to additional shares that may be issued by the Company in order to maintain their proportionate ownership of the common stock. Further, if the holders of Conversion Shares sell substantial amounts of our common stock in the public market, or if the market perceives that these sales might occur, the market price of our common stock could fall.

Further, to the extent that the additional authorized shares of common stock are issued in the future or are used in connection with securities convertible into or exercisable for shares of common stock, they may decrease existing stockholders’ percentage of equity ownership and thus could be dilutive to existing stockholders. Depending on the price at which such shares are issued, they also may have a negative effect on the